Cambridge, MA, United States of America

Ryo Takeuchi

This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Bayer Healthcare LLC, Crispr Therapeutics Ag. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryo Takeuchi. Retrieved from https://idiyas.com/inventor/ryo-takeuchi-3ta00jry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ryo Takeuchi

Introduction: Ryo Takeuchi is a pioneering inventor based in Cambridge, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Ryo Takeuchi's recent patents include advancements in artificial intelligence algorithms for autonomous vehicles and innovative medical devices for remote patient monitoring.

Career Highlights: With a background in electrical engineering and computer science, Ryo Takeuchi has led research teams at renowned tech companies, focusing on developing cutting-edge solutions for complex challenges.

Collaborations: Throughout his career, Ryo Takeuchi has collaborated with leading universities and research institutions to push the boundaries of innovation, resulting in several successful projects and patents.

Conclusion: Ryo Takeuchi's relentless pursuit of innovation and collaboration continues to shape the future of technology, making him a prominent figure in the world of inventors and patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…